Literature DB >> 17056523

Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals.

Thanh V Nguyen1, Yuehai Ke, Eric E Zhang, Gen-Sheng Feng.   

Abstract

It is well known that T cell differentiation and maturation in the thymus is tightly controlled at multiple checkpoints. However, the molecular mechanism for the control of this developmental program is not fully understood. A number of protein tyrosine kinases, such as Zap-70, Lck, and Fyn, have been shown to promote signals required for thymocyte development, whereas a tyrosine phosphatase Src homology domain-containing tyrosine phosphatase (Shp)1 has a negative effect in pre-TCR and TCR signaling. We show in this study that Shp2, a close relative of Shp1, plays a positive role in T cell development and functions. Lck-Cre-mediated deletion of Shp2 in the thymus resulted in a significant block in thymocyte differentiation/proliferation instructed by the pre-TCR at the beta selection step, and reduced expansion of CD4(+) T cells. Furthermore, mature Shp2(-/-) T cells showed decreased TCR signaling in vitro. Mechanistically, Shp2 acts to promote TCR signaling through the ERK pathway, with impaired activation of ERK kinase observed in Shp2(-/-) T cells. Thus, our results provide physiological evidence that Shp2 is a common signal transducer for pre-TCR and TCR in promoting T cell maturation and proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056523     DOI: 10.4049/jimmunol.177.9.5990

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.

Authors:  Hui Huang; Andrew J Woo; Zachary Waldon; Yocheved Schindler; Tyler B Moran; Helen H Zhu; Gen-Sheng Feng; Hanno Steen; Alan B Cantor
Journal:  Genes Dev       Date:  2012-07-03       Impact factor: 11.361

2.  SHP2 is a target of the immunosuppressant tautomycetin.

Authors:  Sijiu Liu; Zhihong Yu; Xiao Yu; Sheng-Xiong Huang; Yinggang Luo; Li Wu; Weihua Shen; Zhenyun Yang; Lina Wang; Andrea M Gunawan; Rebecca J Chan; Ben Shen; Zhong-Yin Zhang
Journal:  Chem Biol       Date:  2011-01-28

3.  T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2.

Authors:  Baoxia Dong; Yubo Gao; Xuan Zheng; Guangxun Gao; Hongtao Gu; Xiequn Chen; Jinyi Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  A VISTA on PD-1H.

Authors:  Yang Liu
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

5.  Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation.

Authors:  Keisuke Maeshima; Stephanie M Stanford; Deepa Hammaker; Cristiano Sacchetti; Li-Fan Zeng; Rizi Ai; Vida Zhang; David L Boyle; German R Aleman Muench; Gen-Sheng Feng; John W Whitaker; Zhong-Yin Zhang; Wei Wang; Nunzio Bottini; Gary S Firestein
Journal:  JCI Insight       Date:  2016-05-19

Review 6.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.

Authors:  Yuanyuan Zha; Thomas F Gajewski
Journal:  Cell Immunol       Date:  2007-09-25       Impact factor: 4.868

Review 8.  Protein tyrosine phosphatases: structure, function, and implication in human disease.

Authors:  Lutz Tautz; David A Critton; Stefan Grotegut
Journal:  Methods Mol Biol       Date:  2013

9.  Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Authors:  Jianxun Wang; Masayuki Mizui; Li-Fan Zeng; Roderick Bronson; Michele Finnell; Cox Terhorst; Vasileios C Kyttaris; George C Tsokos; Zhong-Yin Zhang; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

10.  The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions.

Authors:  Jennifer A Young; Amy M Becker; Jennifer J Medeiros; Virginia S Shapiro; Andrew Wang; J David Farrar; Timothy A Quill; Rob Hooft van Huijsduijnen; Nicolai S C van Oers
Journal:  Mol Immunol       Date:  2008-07-09       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.